REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Beigene, Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Beigene, Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Beigene, Ltd. focuses on the research, development, production and commercialization of innovative drugs. The company was founded in 2010 and headquartered in Beijing City, China.

Headquarters
北京市昌平区中关村生命科学园科学园路30号
Beijing; Beijing; Postal Code: 102206

Contact Details: Purchase the Beigene, Ltd. report to view the information.

Website: http://www.beigene.cn

Basic Information
Total Employees:
Purchase the Beigene, Ltd. report to view the information.
Outstanding Shares:
Purchase the Beigene, Ltd. report to view the information.
Registered Capital:
Purchase the Beigene, Ltd. report to view the information.
Financial Auditors:
Purchase the Beigene, Ltd. report to view the information.
Incorporation Date:
October 28, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
11.1%
Purchase this report to view the information.
10.8%
Purchase this report to view the information.
8.2%
Purchase this report to view the information.
0.39%
Purchase this report to view the information.
0.23%
Subsidiaries
Beigene (Beijing) Co., Ltd.
100%
Beigene (Canada) Ulc (Canada)
100%
Beigene (Guangzhou) Innovation Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Beigene, Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
79.01%▲
Total operating revenue
80.85%▲
Operating profit (EBIT)
53.32%▲
EBITDA
41.92%▲
Net Profit (Loss) for the Period
54.99%▲
Total assets
-8.58%▼
Total equity
-18.78%▼
Operating Profit Margin (ROS)
-16.45%▼
Net Profit Margin
-15.39%▼
Return on Equity (ROE)
-18.47%▼
Debt to Equity Ratio
23.32%▲
Quick Ratio
1.62%▲
Cash Ratio
1.47%▲

Similar companies

Shanghai Pharmaceuticals Holding Co.,Ltd
 
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
 
Zjamp Group Co., Ltd.
Anhui Guangxin Agrochemical Co., Ltd.
 
Hubei Jumpcan Pharmaceutical Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
 
Zhejiang Orient Gene Biotech Co., Ltd
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo